Search research articles
Contact Us
Filters
Showing results (51-60 of 100) with videos related to
Page
of 10
Sort By:
Investigational New Drugs
|
January 1, 1994
A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma
M R Grever, J Benedetti, S P Balcerzak, et al.
Cancer Research
|
February 15, 1995
Efficacy of the quinocarmycins KW2152 and DX-52-1 against human melanoma lines growing in culture kand in mice
J Plowman, D J Dykes, V L Narayanan, et al.
Leukemia & Lymphoma
|
November 8, 2001
Carboxyamido-triazole (CAI)--a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells
J K Waselenko, C A Shinn, C R Willis, et al.
Journal of the National Cancer Institute
|
November 21, 1990
Phase II investigation of pentostatin in multiple myeloma: a Southwest Oncology Group study
M R Grever, J Crowley, S Salmon, et al.
Cancer
|
December 1, 1989
Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative Study
D R Head, K Kopecky, J M Bennett, et al.
Cancer Research
|
July 1, 1995
Tyrphostin AG17, [(3,5-Di-tert-butyl-4-hydroxybenzylidene)- malononitrile], inhibits cell growth by disrupting mitochondria
A M Burger, G Kaur, M C Alley, et al.
The Cancer Journal From Scientific American
|
January 1, 1996
Antiproliferative effect in vitro and antitumor activity in vivo of brefeldin A
E A Sausville, K L Duncan, A Senderowicz, et al.
Experimental Hematology
|
May 30, 2001
UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism
J C Byrd, C Shinn, C R Willis, et al.
Life Sciences
|
January 1, 1995
In vivo cultivation of tumor cells in hollow fibers
M G Hollingshead, M C Alley, R F Camalier, et al.
Investigational New Drugs
|
May 1, 1990
Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study
E H Kraut, J J Crowley, M R Grever, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 100) with videos related to
Sort By:
Page
of 10
Investigational New Drugs
|
January 1, 1994
A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma
M R Grever, J Benedetti, S P Balcerzak, et al.
Cancer Research
|
February 15, 1995
Efficacy of the quinocarmycins KW2152 and DX-52-1 against human melanoma lines growing in culture kand in mice
J Plowman, D J Dykes, V L Narayanan, et al.
Leukemia & Lymphoma
|
November 8, 2001
Carboxyamido-triazole (CAI)--a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells
J K Waselenko, C A Shinn, C R Willis, et al.
Journal of the National Cancer Institute
|
November 21, 1990
Phase II investigation of pentostatin in multiple myeloma: a Southwest Oncology Group study
M R Grever, J Crowley, S Salmon, et al.
Cancer
|
December 1, 1989
Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative Study
D R Head, K Kopecky, J M Bennett, et al.
Cancer Research
|
July 1, 1995
Tyrphostin AG17, [(3,5-Di-tert-butyl-4-hydroxybenzylidene)- malononitrile], inhibits cell growth by disrupting mitochondria
A M Burger, G Kaur, M C Alley, et al.
The Cancer Journal From Scientific American
|
January 1, 1996
Antiproliferative effect in vitro and antitumor activity in vivo of brefeldin A
E A Sausville, K L Duncan, A Senderowicz, et al.
Experimental Hematology
|
May 30, 2001
UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism
J C Byrd, C Shinn, C R Willis, et al.
Life Sciences
|
January 1, 1995
In vivo cultivation of tumor cells in hollow fibers
M G Hollingshead, M C Alley, R F Camalier, et al.
Investigational New Drugs
|
May 1, 1990
Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study
E H Kraut, J J Crowley, M R Grever, et al.
Page
of 10